Ovid Therapeutics
OVID
OVID
80 hedge funds and large institutions have $131M invested in Ovid Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-8
Holders Change %
-9.09%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
18
Reduced
30
Closed
28
Calls
$1.78M
Puts
$2.83M
Net Calls
-$1.05M
Net Calls Change
+$1.72M
Top Buyers
| 1 |
GC
Globeflex Capital
San Diego,
California
|
+$3.95M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.42M |
| 3 |
Millennium Management
New York
|
+$2.99M |
| 4 |
Two Sigma Investments
New York
|
+$1.13M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$835K |
Top Sellers
| 1 |
BlackRock
New York
|
-$9.77M |
| 2 |
State Street
Boston,
Massachusetts
|
-$4.09M |
| 3 |
Goldman Sachs
New York
|
-$2.49M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.89M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.56M |
